vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $104.1M, roughly 2.0× GRID DYNAMICS HOLDINGS, INC.). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -1.4%, a 9.7% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 3.7%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 12.0%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
COLL vs GDYN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $104.1M |
| Net Profit | $17.0M | $-1.5M |
| Gross Margin | 62.5% | 34.8% |
| Operating Margin | 29.6% | 61.7% |
| Net Margin | 8.3% | -1.4% |
| Revenue YoY | 12.9% | 3.7% |
| Net Profit YoY | 35.3% | -150.6% |
| EPS (diluted) | $0.48 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | $205.4M | $106.2M | ||
| Q3 25 | $209.4M | $104.2M | ||
| Q2 25 | $188.0M | $101.1M | ||
| Q1 25 | $177.8M | $100.4M | ||
| Q4 24 | $181.9M | $100.3M | ||
| Q3 24 | $159.3M | $87.4M | ||
| Q2 24 | $145.3M | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | $17.0M | $306.0K | ||
| Q3 25 | $31.5M | $1.2M | ||
| Q2 25 | $12.0M | $5.3M | ||
| Q1 25 | $2.4M | $2.9M | ||
| Q4 24 | $12.5M | $4.5M | ||
| Q3 24 | $9.3M | $4.3M | ||
| Q2 24 | $19.6M | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | 62.5% | 34.0% | ||
| Q3 25 | 61.7% | 33.3% | ||
| Q2 25 | 57.7% | 34.1% | ||
| Q1 25 | 54.8% | 36.8% | ||
| Q4 24 | 54.0% | 36.9% | ||
| Q3 24 | 60.8% | 37.4% | ||
| Q2 24 | 62.5% | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | 29.6% | 0.5% | ||
| Q3 25 | 29.7% | -0.2% | ||
| Q2 25 | 18.7% | -0.1% | ||
| Q1 25 | 12.2% | -2.0% | ||
| Q4 24 | 20.9% | 1.3% | ||
| Q3 24 | 21.9% | 2.4% | ||
| Q2 24 | 32.7% | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | 8.3% | 0.3% | ||
| Q3 25 | 15.0% | 1.1% | ||
| Q2 25 | 6.4% | 5.2% | ||
| Q1 25 | 1.4% | 2.9% | ||
| Q4 24 | 6.9% | 4.5% | ||
| Q3 24 | 5.9% | 4.9% | ||
| Q2 24 | 13.5% | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $0.48 | $0.01 | ||
| Q3 25 | $0.84 | $0.01 | ||
| Q2 25 | $0.34 | $0.06 | ||
| Q1 25 | $0.07 | $0.03 | ||
| Q4 24 | $0.36 | $0.06 | ||
| Q3 24 | $0.27 | $0.05 | ||
| Q2 24 | $0.52 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $327.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $530.1M |
| Total Assets | $1.7B | $605.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | $386.7M | $342.1M | ||
| Q3 25 | $285.9M | $338.6M | ||
| Q2 25 | $222.2M | $336.8M | ||
| Q1 25 | $197.8M | $325.5M | ||
| Q4 24 | $162.8M | $334.7M | ||
| Q3 24 | $120.0M | $231.3M | ||
| Q2 24 | $271.6M | $256.0M |
| Q1 26 | — | $530.1M | ||
| Q4 25 | $301.7M | $542.1M | ||
| Q3 25 | $274.8M | $537.7M | ||
| Q2 25 | $232.2M | $532.2M | ||
| Q1 25 | $234.4M | $517.4M | ||
| Q4 24 | $228.8M | $517.8M | ||
| Q3 24 | $234.3M | $400.2M | ||
| Q2 24 | $216.6M | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | $1.7B | $612.9M | ||
| Q3 25 | $1.6B | $613.2M | ||
| Q2 25 | $1.6B | $608.9M | ||
| Q1 25 | $1.6B | $590.9M | ||
| Q4 24 | $1.7B | $592.2M | ||
| Q3 24 | $1.6B | $477.3M | ||
| Q2 24 | $1.1B | $443.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $9.9M | ||
| Q3 25 | $78.4M | $7.0M | ||
| Q2 25 | $72.4M | $14.4M | ||
| Q1 25 | $55.4M | $9.4M | ||
| Q4 24 | $84.6M | $7.1M | ||
| Q3 24 | $-9.0M | $9.2M | ||
| Q2 24 | $67.4M | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $6.1M | ||
| Q3 25 | $78.3M | $2.9M | ||
| Q2 25 | $72.4M | $10.2M | ||
| Q1 25 | $54.6M | $6.0M | ||
| Q4 24 | $84.1M | $4.4M | ||
| Q3 24 | $-9.2M | $5.9M | ||
| Q2 24 | $67.1M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 5.7% | ||
| Q3 25 | 37.4% | 2.8% | ||
| Q2 25 | 38.5% | 10.1% | ||
| Q1 25 | 30.7% | 6.0% | ||
| Q4 24 | 46.2% | 4.4% | ||
| Q3 24 | -5.8% | 6.8% | ||
| Q2 24 | 46.2% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 3.6% | ||
| Q3 25 | 0.1% | 3.9% | ||
| Q2 25 | 0.0% | 4.1% | ||
| Q1 25 | 0.4% | 3.3% | ||
| Q4 24 | 0.3% | 2.6% | ||
| Q3 24 | 0.2% | 3.7% | ||
| Q2 24 | 0.2% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 32.34× | ||
| Q3 25 | 2.49× | 5.92× | ||
| Q2 25 | 6.05× | 2.73× | ||
| Q1 25 | 22.92× | 3.21× | ||
| Q4 24 | 6.75× | 1.56× | ||
| Q3 24 | -0.96× | 2.15× | ||
| Q2 24 | 3.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
